MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies _ Alzheimers & Dementia
Lexeo Therapeutics Inc. (NASDAQ: LXEO)*
Organization & Developments: Lexeo Therapeutics
Parents
Lexeo Therapeutics Inc. (NASDAQ: LXEO)*
Children
*LEXEO Therapeutics is a fully integrated clinical-stage gene therapy company advancing disease-modifying treatments for genetic cardiovascular conditions and genetic conditions of the central nervous system (CNS).
*Progressing adeno-associated virus-based gene therapy for genetically defined cardiovascular and central nervous system diseases
2024: Lexeo Therapeutics Scores Positive Early Data for APOE4-Alzheimer’s Gene Therapy
2024: Lexeo Therapeutics: Only Smallcap Gene Therapy For Alzheimer's
2024: Lexeo: Targeted Alzheimer's Disease Treatment Approach Might Pay Off
Jumps
Finance & Acquisitions: Lexeo Therapeutics
Key People: Lexeo Therapeutics